Anti-YRDC antibody (STJA0004554)

SKU:
STJA0004554

Current Stock:
Host: Rabbit
Applications: WB/ELISA
Reactivity: Human/Mouse/Rat
Note: FOR SCIENTIFIC EDUCATIONAL RESEARCH USE ONLY (RUO). MUST NOT BE USED IN DIAGNOSTIC OR OTHER MEDICAL APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-Threonylcarbamoyl-Amp Synthase is suitable for use in Western Blot and ELISA research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: PBS with 0.05% NaN3 and 40% Glycerol, pH7.4
Purification: Antigen affinity purification
Concentration: 0.5 mg/mL
Dilution Range: WB 1:500-1:2000
Storage Instruction: Store at-20°C for long term, and avoid freeze-thaw cycles.
Gene Symbol: YRDC
Gene ID: 79693
Uniprot ID: YRDC_HUMAN
Immunogen: Synthetic peptide of human YRDC
Tissue Specificity Ubiquitously expressed.
Function Cytoplasmic and mitochondrial threonylcarbamoyl-AMP synthase required for the formation of a threonylcarbamoyl group on adenosine at position 37 (t(6)A37) in tRNAs that read codons beginning with adenine. Catalyzes the conversion of L-threonine, HCO(3)(-)/CO(2) and ATP to give threonylcarbamoyl-AMP (TC-AMP) as the acyladenylate intermediate, with the release of diphosphate. Participates in t(6)A37 formation in cytoplasmic and mitochondrial tRNAs. May regulate the activity of some transporters.
Protein Name Threonylcarbamoyl-Amp Synthase
Dopamine Receptor-Interacting Protein 3
Ischemia/Reperfusion-Inducible Protein Homolog
Hirip
Cellular Localisation Cytoplasm
Mitochondrion
Cell Membrane
Peripheral Membrane Protein
A Large Fraction Localizes In The Cytoplasm
Whereas A Smaller Fraction Is Imported To Mitochondria
Alternative Antibody Names Anti-Threonylcarbamoyl-Amp Synthase antibody
Anti-Dopamine Receptor-Interacting Protein 3 antibody
Anti-Ischemia/Reperfusion-Inducible Protein Homolog antibody
Anti-Hirip antibody
Anti-YRDC antibody
Anti-DRIP3 antibody
Anti-IRIP antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance